Enterostatin (VPDPR) and Its Peptide Fragment DPR Reduce Serum Cholesterol Levels after Oral Administration in Mice.

Discusses the ability of enterostatin and its peptide fragment DPR to reduce serum cholesterol levels after oral administration in mice. Drug dosage; Inhibition of the secretion of insulin after peripheral administration; Time course to reduce serum cholesterol levels; Mechanism for hypocholesterolemic effect.